Paper5639737
Antifibrinolytic therapy for intracranial aneurysms.
Mullan S and 1 other. J Neurosurg, 1968. Cited by 127 papers, by iCite.
Cite this record
ConductScience Library. Antifibrinolytic therapy for intracranial aneurysms. Papers, record 5639737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5639737
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminocaproates | Major topic |
| Intracranial Aneurysm | Major topic |
| Subarachnoid Hemorrhage | Major topic |
| Humans |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 127 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36350005 | Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/36350005 | PubMed |
| 29305756 | On Aneurysmal Rupture and Rerupture. | Neurocrit Care | 2018 | https://conductscience.org/library/papers/29305756 | PubMed |
| 18818887 | Perioperative use of recombinant factor VII to prevent intraoperative aneurysm rupture in high risk patients: a preliminary safety evaluation. | Neurocrit Care | 2009 | https://conductscience.org/library/papers/18818887 | PubMed |
| 18730851 | The Use of AMICAR(R) in Subarachnoid Hemorrhage. | Calif Med | 1972 | https://conductscience.org/library/papers/18730851 | PubMed |
| 7376944 | Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid. | Acta Neurochir (Wien) | 1980 | https://conductscience.org/library/papers/7376944 | PubMed |
| 7229645 | Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm. | J Neurol Neurosurg Psychiatry | 1981 | https://conductscience.org/library/papers/7229645 | PubMed |
| 7048863 | Antifibrinolytic treatment in subarachnoid haemorrhage: present state. | Acta Neurochir (Wien) | 1982 | https://conductscience.org/library/papers/7048863 | PubMed |
| 7031186 | Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage. | J Neurol Neurosurg Psychiatry | 1981 | https://conductscience.org/library/papers/7031186 | PubMed |
| 7000850 | Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage. | J Clin Pathol Suppl (R Coll Pathol) | 1980 | https://conductscience.org/library/papers/7000850 | PubMed |
| 5576904 | Ruptured intracranial aneurysms. | Proc R Soc Med | 1971 | https://conductscience.org/library/papers/5576904 | PubMed |
| 5576488 | Use of an anti-fibrinolytic agent (tranexamic acid) in the management of ruptured intracranial aneurysms. | Postgrad Med J | 1971 | https://conductscience.org/library/papers/5576488 | PubMed |
| 3546604 | Antifibrinolytic agents in subarachnoid haemorrhage. | J Neurol | 1987 | https://conductscience.org/library/papers/3546604 | PubMed |
| 3177035 | Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: a retrospective clinical study. | Acta Neurochir (Wien) | 1988 | https://conductscience.org/library/papers/3177035 | PubMed |
| 2407050 | Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. | Acta Neurochir (Wien) | 1990 | https://conductscience.org/library/papers/2407050 | PubMed |
| 2205078 | Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid. | Acta Neurochir (Wien) | 1990 | https://conductscience.org/library/papers/2205078 | PubMed |
| 932226 | Fibrin-fibrinogen degradation products in cerebrospinal fluid. | J Clin Pathol | 1976 | https://conductscience.org/library/papers/932226 | PubMed |
| 878925 | Fibrinolytic activity in the walls of cerebral saccular aneurysms. | Acta Neurochir (Wien) | 1977 | https://conductscience.org/library/papers/878925 | PubMed |
| 649775 | Coagulation and fibrinolytic activity of cerebrospinal fluid. | J Clin Pathol | 1978 | https://conductscience.org/library/papers/649775 | PubMed |
| 452972 | Early intracranial operations for ruptured aneurysms. | Acta Neurochir (Wien) | 1979 | https://conductscience.org/library/papers/452972 | PubMed |
| 346153 | Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms? | Br Med J | 1978 | https://conductscience.org/library/papers/346153 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5639737
GET https://conductscience.org/api/papers/v1/5639737/cited_by?page=2